These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


209 related items for PubMed ID: 12417879

  • 21. Methacholine challenge as a clinical bioassay of pulmonary delivery of a long-acting β₂-adrenergic agonist.
    Prabhakaran S, Shuster J, Ahrens R, Hendeles L.
    Pharmacotherapy; 2011 May; 31(5):449-57. PubMed ID: 21923426
    [Abstract] [Full Text] [Related]

  • 22. The protective effect of salbutamol inhaled using different devices on methacholine bronchoconstriction.
    Giannini D, Di Franco A, Bacci E, Dente FL, Taccola M, Vagaggini B, Paggiaro P.
    Chest; 2000 May; 117(5):1319-23. PubMed ID: 10807817
    [Abstract] [Full Text] [Related]

  • 23. Regular inhaled salbutamol : effect on airway responsiveness to methacholine and adenosine 5'-monophosphate and tolerance to bronchoprotection.
    Jokic R, Swystun VA, Davis BE, Cockcroft DW.
    Chest; 2001 Feb; 119(2):370-5. PubMed ID: 11171711
    [Abstract] [Full Text] [Related]

  • 24. In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol.
    Aziz I, Lipworth BJ.
    J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):816-22. PubMed ID: 10329815
    [Abstract] [Full Text] [Related]

  • 25. Efficacy response of inhaled HFA-albuterol delivered via the breath-actuated Autohaler inhalation device is comparable to dose in patients with asthma.
    Gross G, Cohen RM, Guy H.
    J Asthma; 2003 May; 40(5):487-95. PubMed ID: 14529098
    [Abstract] [Full Text] [Related]

  • 26. Interpretation of positive results of a methacholine inhalation challenge and 1 week of inhaled bronchodilator use in diagnosing and treating cough-variant asthma.
    Irwin RS, French CT, Smyrnios NA, Curley FJ.
    Arch Intern Med; 1997 Sep 22; 157(17):1981-7. PubMed ID: 9308510
    [Abstract] [Full Text] [Related]

  • 27. Long-term safety study of levalbuterol administered via metered-dose inhaler in patients with asthma.
    Hamilos DL, D'Urzo A, Levy RJ, Marcus M, Tripp K, Parsey M, Baumgartner RA, McVicar WK.
    Ann Allergy Asthma Immunol; 2007 Dec 22; 99(6):540-8. PubMed ID: 18219836
    [Abstract] [Full Text] [Related]

  • 28. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
    Kalra S, Swystun VA, Bhagat R, Cockcroft DW.
    Chest; 1996 Apr 22; 109(4):953-6. PubMed ID: 8635376
    [Abstract] [Full Text] [Related]

  • 29. Nitrogen oxides reduce albuterol-induced bronchodilation in patients with bronchial asthma.
    Kanazawa H, Hirata K, Yoshikawa J.
    Respiration; 2002 Apr 22; 69(6):490-5. PubMed ID: 12457000
    [Abstract] [Full Text] [Related]

  • 30. Prospective, open-label assessment of albuterol sulfate hydrofluoroalkane metered-dose inhaler with new integrated dose counter.
    Given J, Taveras H, Iverson H, Lepore M.
    Allergy Asthma Proc; 2013 Apr 22; 34(1):42-51. PubMed ID: 23265285
    [Abstract] [Full Text] [Related]

  • 31. The utility of methacholine airway responsiveness measurements in evaluating anti-asthma drugs.
    Inman MD, Hamilton AL, Kerstjens HA, Watson RM, O'Byrne PM.
    J Allergy Clin Immunol; 1998 Mar 22; 101(3):342-8. PubMed ID: 9525450
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial.
    Berger WE, Milgrom H, Skoner DP, Tripp K, Parsey MV, Baumgartner RA, Xopenex Pediatric Asthma Group.
    Curr Med Res Opin; 2006 Jun 22; 22(6):1217-26. PubMed ID: 16846555
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Comparison of the protective effect amongst anticholinergic drugs on methacholine-induced bronchoconstriction in asthma.
    Sposato B, Barzan R, Calabrese A, Franco C.
    J Asthma; 2008 Jun 22; 45(5):397-401. PubMed ID: 18569233
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial.
    Donohue JF, Wise R, Busse WW, Garfinkel S, Zubek VB, Ghafouri M, Manuel RC, Schlenker-Herceg R, Bleecker ER.
    BMC Pulm Med; 2016 Apr 30; 16(1):65. PubMed ID: 27130202
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Population pharmacodynamic model of bronchodilator response to inhaled albuterol in children and adults with asthma.
    Blake K, Madabushi R, Derendorf H, Lima J.
    Chest; 2008 Nov 30; 134(5):981-989. PubMed ID: 18583517
    [Abstract] [Full Text] [Related]

  • 38. Repeat dosing of albuterol via metered-dose inhaler in infants with acute obstructive airway disease: a randomized controlled safety trial.
    Kaashmiri M, Shepard J, Goodman B, Lincourt WR, Trivedi R, Ellsworth A, Davis AM.
    Pediatr Emerg Care; 2010 Mar 30; 26(3):197-202. PubMed ID: 20179658
    [Abstract] [Full Text] [Related]

  • 39. A comparison of the efficacy and tolerability of single doses of HFA 134a albuterol and CFC albuterol in mild-to-moderate asthmatic patients.
    Langley SJ, Sykes AP, Batty EP, Masterson CM, Woodcock A.
    Ann Allergy Asthma Immunol; 2002 May 30; 88(5):488-93. PubMed ID: 12027070
    [Abstract] [Full Text] [Related]

  • 40. Metered dose inhalers: a need for dose counters.
    Holt S, Holt A, Weatherall M, Masoli M, Beasley R.
    Respirology; 2005 Jan 30; 10(1):105-6. PubMed ID: 15691246
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.